Inventurus IPO

Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more. The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers. Inventurus Knowledge Solutions Limited offer a platform that enables healthcare enterprises in outpatient and inpatient care. Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services. Inpatient care refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration. As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management. The company has a team of over 13,528 employees, including 2,612 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia. Their Competitive Strengths: Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations. Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered. Strong brand amongst healthcare organizations and physicians. Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch 215 engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App